Dr. Balaji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
653 North 8th street
Department of Urology, Faculty Clinic, 2nd floor
Jacksonville, FL 32209Phone+1 904-244-7340
Clinical Expertise
- Penile cancer, Biomedical research, Transitional cell carcinoma of the lower urinary tract; Lower urinary tract transitional cell carcinoma; Lower urinary tract TCC; TCC of the lower urinary tract, Cancer genetics, Urologic oncology, Erectile dysfunction, Kidney cancer, Bladder cancer, Cancer pain, Urology, Prostate cancer, Immunotherapy, Sarcomas, Laparoscopy, Robotic surgery, Drug development, Next generation sequencing, Clinical research, Chemotherapy, Medical oncology, Upper tract urothelial carcinoma, Advanced cancer, Metastatic cancer, Precision Medicine, Gene testing, Cancer research, Small molecules, Novel cancer treatment, Kinase, Inhibitor, Open urological surgery, Complex cases, PSA, Testosterone
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urological Oncology, 1997 - 1999
UMass Chan Medical SchoolResidency, Urology, 1993 - 1997
BronxCare Health SystemInternship, Transitional Year, 1992 - 1993- British HospitalsFRCS, Surgery, 1986 - 1992
Madras Medical CollegeClass of 1986
Certifications & Licensure
FL State Medical License 2018 - 2026
NC State Medical License 2010 - 2019
MA State Medical License 1995 - 2011
IL State Medical License 1999 - 2002- American Board of Urology Urology
Clinical Trials
- Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy Start of enrollment: 2016 Jul 01
- International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
Roles: Principal Investigator, Contact
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve Start of enrollment: 2021 Apr 22
Roles: Contact
Publications & Presentations
PubMed
- Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin.Sanjeev Shukla, Teruko Osumi, Mohammed Al-Toubat, Samuel Serrano, Pankaj Kumar Singh
The Prostate. 2025-02-01 - Investigation of radiomic features on MRI images to identify extraprostatic extension in prostate cancer.Kazim Z Gumus, Manuel Menendez, Carlos Gonzalez Baerga, Ira Harmon, Sindhu Kumar
Computer Methods and Programs in Biomedicine. 2025-02-01 - Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate Cancer.Zhouping Wei, Malinda Iluppangama, Jin Qi, Jung W Choi, Alice Yu
Cancer Control. 2024-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
